CGI-879

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCGI-879
Drug Alias NameEphB4 inhibitors (Cellular Genomics)CGI-1032CGI-1087CGI-710CGI-1035 +[10] 
ClassificationSmall molecules
Mechanisms of ActionEphrin type-B receptor 4 antagonistsVascular endothelial growth factor receptor 2 antagonistsAngiogenesis inhibitors +[5] 
TargetsTEK receptor tyrosine kinaseEphrin type-B receptor 4Vascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCGI Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCGI Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A